De Angelis C, Fu X, Cataldo ML, Nardone A, et al. Activation of the interferon signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer. Clin Cancer Res 2021 Feb 3. pii: 1078-0432.CCR-19-4191.
PMID: 33536276